Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 70
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05773092 | A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC | ||
| NCT05245968 | A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101) | ||
| NCT02128243 | Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer | ||
| NCT02246478 | A Study of TAS-205 for Duchenne Muscular Dystrophy | ||
| NCT04104139 | TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer | ||
| NCT00166543 | Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer | ||
| NCT05621447 | A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects | ||
| NCT02261532 | A Phase I Study of TAS-102 in Solid Tumors | ||
| NCT03175029 | Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder. | ||
| NCT04512053 | A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence | ||
| NCT00359567 | Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy | ||
| NCT07641881 | A Bioequivalence Study Between Two Casdatifan Tablet Strengths and Food Effect Study of Casdatifan in Healthy Adult Participants | ||
| NCT02090153 | Study of S-1 Plus LV for Advanced Gastric Cancer | ||
| NCT04920032 | Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas | ||
| NCT02562807 | A Study of TAS-303 in Female Patients With Stress Urinary Incontinence | ||
| NCT00152217 | Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC) | ||
| NCT00639327 | Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer | ||
| NCT00284258 | Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer | ||
| NCT07710885 | Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer | ||
| NCT00152191 | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) | ||
| NCT00602745 | S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen | ||
| NCT02024841 | Intraperitoneal Docetaxel With Cisplatin and TS-ONE for Gastric Cancer With Peritoneal Carcinomatosis | ||
| NCT04608110 | A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome | ||
| NCT00152230 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC) | ||
| NCT04825431 | Mass Balance Study of [14C] TAS-205 in Healthy Volunteers | ||
| NCT00737360 | Phase II Study of TAS-106 to Treat Head and Neck Cancer | ||
| NCT00784290 | Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma | ||
| NCT01824459 | S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients | ||
| NCT01955837 | Study of Trifluridine/Tipiracil (TAS-102) in Patients With Metastatic Colorectal Cancer in Asia | ||
| NCT05568095 | A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body | ||
| NCT00661167 | Phase II Study of ABI-007 for Gastric Cancer | ||
| NCT00498225 | Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer | ||
| NCT04074343 | TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma | ||
| NCT01610479 | A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors | ||
| NCT02602327 | Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases | ||
| NCT00429858 | Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer | ||
| NCT01811277 | SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer | ||
| NCT02943733 | Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs | ||
| NCT00824161 | Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer | ||
| NCT00569699 | Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC) | ||
| NCT02322593 | Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer | ||
| NCT00142350 | A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer | ||
| NCT03605251 | Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis. | ||
| NCT00152243 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC) | ||
| NCT00569335 | Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer | ||
| NCT04923529 | TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma | ||
| NCT05335499 | A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous Urticaria | ||
| NCT00770874 | Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer | ||
| NCT05691660 | A Study of TAS3731 in Healthy Adults | ||
| NCT01679340 | A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery |
